BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Prognosis
94 results:

  • 1. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
    Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Loss of miR-101-3p in melanoma stabilizes genomic integrity, leading to cell death prevention.
    Lämmerhirt L; Kappelmann-Fenzl M; Fischer S; Meier P; Staebler S; Kuphal S; Bosserhoff AK
    Cell Mol Biol Lett; 2024 Mar; 29(1):29. PubMed ID: 38431560
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals.
    Jarmuzek P; Defort P; Kot M; Wawrzyniak-Gramacka E; Morawin B; Zembron-Lacny A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003396
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Teratoma pathology and genomics in anti-NMDA receptor encephalitis.
    Jang Y; Lee K; Lee C; Chu K; Lee SK; Won JK; Lee ST
    Ann Clin Transl Neurol; 2024 Jan; 11(1):225-234. PubMed ID: 37986706
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combining CSPG4-CAR and cd20-CCR for treatment of metastatic melanoma.
    Teppert K; Winter N; Herbel V; Brandes C; Lennartz S; Engert F; Kaiser A; Schaser T; Lock D
    Front Immunol; 2023; 14():1178060. PubMed ID: 37901209
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma.
    Zhou Y; Yan H; Zhou Q; Wang P; Yang F; Yuan Z; Du Q; Zhai B
    Clin Transl Med; 2023 Jul; 13(7):e1328. PubMed ID: 37461251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
    Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
    Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma.
    Zou R; Zhong X; Liang K; Zhi C; Chen D; Xu Z; Zhang J; Liao D; Lai M; Weng Y; Peng H; Pang X; Ji Y; Ke Y; Zhang H; Wang Z; Wang Y
    BMC Cancer; 2023 May; 23(1):403. PubMed ID: 37142967
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.
    Guo Q; Fan Y; Wang Q; Li B; Qiu W; Qi Y; Pan Z; Zhang S; Zhao S; Yang K; Xu H; Li M; Gao Z; Xu J; Wang H; Wang S; Tang Q; Qiu J; Guo X; Deng L; Zhang P; Zhao R; Xue H; Wang C; Li G
    Cell Death Dis; 2023 Feb; 14(2):147. PubMed ID: 36810326
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation.
    Saxena S; Jena B; Mohapatra B; Gupta N; Kalra M; Scartozzi M; Saba L; Suri JS
    Comput Biol Med; 2023 Feb; 153():106492. PubMed ID: 36621191
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization of the tumor-infiltrating lymphocyte landscape in sinonasal mucosal melanoma.
    Ledderose S; Schulz H; Paul T; Ledderose C; Ledderose GJ
    Pathol Res Pract; 2023 Jan; 241():154289. PubMed ID: 36584498
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A Case of Resection of Primary Hepatic Neuroendocrine tumor].
    Suzuki A; Maeda Y; Sakamoto K; Kamei R; Yamamoto T
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1259-1262. PubMed ID: 36412032
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The role of cuproptosis-related gene in the classification and prognosis of melanoma.
    Liu JY; Liu LP; Li Z; Luo YW; Liang F
    Front Immunol; 2022; 13():986214. PubMed ID: 36341437
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Unraveling the peripheral and local role of inflammatory cytokines in glioblastoma survival.
    Cavalheiro VJ; Campos ACP; Lima LGCA; Roça CT; Docema MFL; Lancellotti CLP; Martinez RCR; Pagano RL; Chammas R; Teixeira MJ; Maldaun MVC; Neville IS
    Cytokine; 2023 Jan; 161():156059. PubMed ID: 36272241
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
    Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
    Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Opsoclonus-myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity.
    Du H; Cai W
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29949. PubMed ID: 36094353
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
    Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
    Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Characteristics of tumor infiltrating lymphocytes in sinonasal mucosal melanoma and prognosis for patients.
    Yin G; Guo W; Liu H; Huang Z; Chen X
    Curr Probl Cancer; 2022 Aug; 46(4):100878. PubMed ID: 35752137
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunophenotype of tumor-infiltrating lymphocytes in atypical Spitzoid tumors according to the risk of progression.
    Moysset I; Fuster-Anglada C; Castillo P; Teixido C; Garcia-Herrera A; Marginet M; Lopez I; Costa D; Carrera C; Arance A; Alos L
    Ann Diagn Pathol; 2022 Oct; 60():151985. PubMed ID: 35709617
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line.
    Shi C; Gu Z; Xu S; Ju H; Wu Y; Han Y; Li J; Li C; Wu J; Wang L; Li J; Zhou G; Ye W; Ren G; Zhang Z; Zhou R
    Cancer Commun (Lond); 2022 Jul; 42(7):627-647. PubMed ID: 35666052
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.